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Abstract
Background: Temporomandibular joint (TMJ) arthritis is seen very often (38–87 %) in children with juvenile
idiopathic arthritis (JIA). With contrast enhanced magnetic resonance imaging (MRI) we can detect more cases of
TMJ arthritis than ever before. Previous studies show that HLA II class alleles may have protective or risk importance
in JIA subtypes. Our objective is to identify HLA II class alleles of risk and protection in JIA patients with TMJ arthritis.
Methods: During the period from 2010 to 2015 MRI for TMJ was performed in 85 JIA patients who were genotyped
for HLA- DRB1; DQB1 and DQA1 using RT-PCR with sequence-specific primers. As a control group, data of 100
individuals were taken from the genetic bank of RSU Joint Laboratory of Clinical Immunology and Immunogenetics.
Associations of DRB1; DQB1; DQA1 alleles in patients were examined individually using the χ2 test. P-value (<0.05) and
odds ratio were calculated using EPI INFO 6.0 software.
Results: Out of 85 JIA patients with mean age of 13.7 ± 3.0 years (range 6.9–17.9 years), 59 (69 %) were girls and 26
(31 %) were boys. The mean duration of the disease was 3.07 ± 2.35 years (range 0.2–11.0 year). JIA subtypes were as
follows: seronegative polyarthritis 51 (60 %), seropositive polyarthritis 6(7 %), oligoarthritis extended 7(8 %), oligoarthritis
persistent 2 (2 %) arthritis with enthesitis 14 (17 %), undifferentiated 3 (4 %) and 2 (2 %) systemic arthritis. Two groups
where separated after TMJ MRI exam: first with at least two signs of active inflammation and/or any structural damage
(n = 62); second with no pathologic signs or with slight contrast enhancement (n = 23). We discovered that there are
risk alleles that are found in all JIA patient’s groups (MRI positive and negative groups) versus controls such as
DRB1*07:01, DQB1*03:03; DQB1*05:01. Also some protective alleles as DRB1*18:01, DQB1*06:02–8 were found in overall
JIA group. Alleles DRB1*12:01, DQB1*03:01; DQA1*05:01 were found to be protective for TMJ arthrits.
Conclusion: In our study there were no convincing risk alleles, but there are alleles that probably are protective for
TMJ arthritis like DRB1*12:01, DQB1*03:01; DQA1*05:01.
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Background
Juvenile idiopathic arthritis (JIA) is the most common
autoimmune childhood disease with a main clinical
sign - chronic arthritis. Arthritis in JIA can affect any
joint but the temporomandibular joint (TMJ) is particularly
susceptible to damage. TMJ involvement is seen very often
(38–87 %) and can lead to compromised craniomandibular
function, dentofacial aestethics and morphology as micro-
gnathia, retrognathia, pathologic occlusion and reduced
mouth opening [1–4]. Contrast enhanced magnetic reson-
ance imaging (MRI) as a golden standard for TMJ arthritis
diagnostics has changed perception about the prevalence of
the TMJ arthritis in JIA patients. There is data that it can
be asymptomatic even in 71 % if evaluated with MRI [5, 6];
therefore it is very important to find different risk factors to
identify JIA patients who need early and regular evaluation
of the TMJ with MRI.
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It is known that TMJ arthritis can present with such
clinical symptoms as pain during the jaw movement,
difficulties with chewing solid food, asymmetry with
maximal mouth opening, crepitation, clicking and
other; however these symptoms have high specificity
but low sensitivity [1, 7]. Patients very often do not
complain about TMJ problems or do not connect
these complaints to JIA. Even with careful rheumato-
logic and orthodontic evaluation many cases of TMJ
arthritis can be missed [6]. On the other hand, using
only clinical symptoms it is possible to overdiagnose
TMJ arthritis [8].
To find those JIA patients who need early and regular
TMJ evaluation by MRI, we have to take into account
not only subjective complaints and symptoms but also
the type and course of the disease, it’s activity and
laboratory measurements. Several risk factors for TMJ
arthritis have been described such as polyarticular
course of the disease, arthritis in upper extremities,
younger age and higher ESR at the beginning of the dis-
ease, but HLA-B27 in previous studies was thought to
be protective [1]. Other studies show that TMJ arthritis
prevalence in different JIA groups is not significantly dif-
ferent. It is known that there are cases when TMJ arth-
ritis can develop with no other joint involvement and no
obvious laboratory or clinical risk factors can be found
in these cases [3].
It is known that the course of disease, including the
involvement of certain joints in case of JIA, can have
genetic predisposition. HLA Class I and Class II genes
are described as genetic risk factors for JIA along with
PTPN22 gene and IL2RA/CD 25 gene. The combination
of both general autoimmune genes and JIA-specific
genes contributes to the different disease phenotypes [9].
There are reports that different HLA II class alleles are
with protective or risk importance in JIA subtypes. JIA is
very heterogeneous group of diseases and beside 7 sub-
types of JIA, there are still significant variations, especially
within the polyarticular disease. HLA typing data may
provide further information for JIA subtypes and in the
future it could be used as a diagnostic criterion [10]. We
speculate that TMJ arthritis could be more characteristic
for patients with definite HLA II class alleles.
As stated previously, it is very important to use different
risk factors starting from gender, age, disease type, labora-
tory parameters, clinical subjective and objective signs and
also genetic factors to detect JIA patients who need early
and regular TMJ evaluation with MRI. It can change
therapeutic tactics - local (intraarticular steroids) or
systemic (addition or change of biological medica-
tion), that can prevent further damage of TMJ. The
aim of our study was to identify possible HLA II class
alleles of risk and protection in JIA patients with TMJ
involvement.
Methods
We performed the retrospective study with 85 JIA pa-
tients treated at Children’s University hospital who had a
MRI exam for TMJ during the period from 2010 to
2015. All of the patients were diagnosed with different
JIA types using the International League of Associations
for Rheumatology (ILAR) criteria. Almost all of them
had a polyarticular disease course according to the
American College of Rheumatology (ACR) JIA treatment
groups. Approval from Central Medical Ethics Committee
of Latvia was obtained and patients’ parents and patients
had signed the written consent form for participating in
the study.
Most of the patients were evaluated with MRI because
of subjective complains and/or objective findings from
TMJ. 11 patients were without subjective complaints
and/or objective signs of TMJ arthritis. TMJ MRI with
contrast enhancement was done with standard T1, T2
FS (fat saturation) in coronar plane; T1, T2 sagitally;
after contrast enhancement (0, 2 mmol/kg) T1 sagitally
and T1 axially (8–10 min after injection).
Depending on MRI findings, patients were divided into
two groups: the first group had active signs of synovitis
[contrast enhancement (excluding light and symmetric
contrast enhancement), effusion or pannus, bone
oedema] and/or joint structure damage as flattening of
the mandibular head, flattening of the fossa, osteophytes
and erosions. The second group did not have any active
or chronic damage findings of the TMJ arthritis or had
light and symmetric contrast enhancement that can be
considered as a normal finding [11]. Characteristics of
these two groups where analysed using STATA program.
Pearson’s correlation coefficient and Fisher’s exact test
where used (P < 0,05). In order to obtain 80 % power of
the study and to detect protective OR 0.2 with p < 0.05,
assuming prevalence among controls 70 % and cases
30 % it was calculated that at least 36 cases and 18 con-
trols (if Case-control ratio is 0.5) had to be included.
The immunogenetic part of the study was done at Riga
Stradiņš University (RSU) Joint Laboratory of Clinical
Immunology and Immunogenetics (JLCII). As a control
group, samples of 100 healthy individuals from the JLCII
genetic bank were utilized. The DNA was extracted from
peripheral blood, by using QiagenQIAamp DNA kit
reagents as per the manufacturer’s protocol [12]. The
quality and quantity of DNA was checked by using
Qubit ® fluorometer (Invitrogen USA). HLA typing tests
and group data of healthy donors HLA genotyping was
done using mutliprimer realtime polymerase chain reac-
tion (RT-PCR) method. Patients and controls were fully
genotyped for HLA- DRB1* 01:01 to 18:01 specificity,
DQA1*01:01, 01:02, 01:03, 04:01, 06:01, and for
DQB1*02:01-02:02, *03:01-03:05, *04:01-04:02, *05:01-
05:04, and *06:01- 06:08 using Real-time PCR, qualitative
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analysis, melting curve analysis that is manufactured in
Russia, “DNA-Technology”. Amplification was done
using Real-Time PCR Thermal Cycler”DT-Lite” with
four channels and 48 wells. (DNA-Technology, Russia).
The reaction mixture was subjected to 35 amplification
cycles, each consisting of denaturation at 94 °C (60 s),
followed by one cycle, annealing at 94 °C (20 s), 67 °C (2 s)
followed by seven cycles and extension at 93 °C (5 s), 65 °C
(4 s), with a final extension instep with 35 cycles [13].
Associations of DRB1, DQB1 and DQA1 alleles among
patient group were examined individually using the χ2
test (P-value <0,05). Odds ratios (OR) were calculated
using EPI INFO software version 6 with 95 % confidence
intervals and Fisher correction for small numbers [14].
Results and discussion
Results
There were 85 JIA patients with mean age of 13.7 (±3.0)
years (range 6.9–17.9 years); 59 (69.4 %) girls and 26
(30.6 %) boys. The median duration of the disease before
the MRI exam was 3.1(IQR 0.2–11) years. JIA subtypes
were as follows: seronegative polyarthritis 51 (60 %),
seropositive polyarthritis 6 (7 %), oligoarthritis extended
7 (8 %), oligoarthritis persistent 2 (2 %) arthritis with
enthesitis 14 (17 %), undifferentiated 3 (4 %) and 2 (2 %)
systemic arthritis patients.
After the MRI exam, we divided JIA patients into two
groups – one group with TMJ arthritis findings (MRI
positive group) and the other without (MRI negative
Table 1 Characteristics of JIA patients with and without TMJ arthritis confirmed by MRI
Characteristics With TMJ arthritis (n = 62) Without TMJ arthritis (n = 23) Total JIA (n = 85)
Demographics
Gender:
Female n (%) 47(75.8) 12(52.2) 59(69.4)
Male n (%) 15(24.2) 11(47.8) 26(30.6)
P value 0.04
Mean age at the time of MRI Years (± SD) 14.2(±2.6) 12.3 (±3.6) 13.7 (±3.0)
P value 0.01
Disease characteristics
Disease duration in years 2.6(0,2–11) 3(0.6–6) 3.1(0.2–11)
Median (IQR)
P value 0.45
Years from the diagnosis 1.8(0–10) 2.2(0–7) 1.9(0–10)
Median (IQR)
P value 0.07
Active joint counta Median (IQR) 7.8(0–22) 7.7(0–20) 7.8(0–22)
P value 0.81
Laboratory characteristics
ESR 12.8(2120) 6(2–20) 10.9(2–120)
Median (IQR)
P value 0.07
CRO 7.6(0180) 0.4(0–1.83) 5.6(0–180)
Median (IQR)
P value 0.03
ANA positive n (%) 8(38.1) 14(23.3) 22(27.2)
P value 0.19
RF positive n (%) 6(9.8) 0(0) 6(7.1)
P value 0.12
HLA B27 positive 15(24.2) 3(13.0) 18(21.2)
n (%)
P value 0.25
aActive joint count - joints with non-bony swelling or limitation of motion with either pain on motion or tenderness to palpation and also those where we have
detected signs of arthritis using ultrasound or MRI
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group). The demographics of these two groups can be
seen in the Table 1. There were statistically significant
more girls in the TMJ arthritis group (p = 0.04). Also
these patients were older - 14.2(±2.6) years (p = 0.01).
There were no statistically significant differences
between two groups in such parameters as disease
duration, years from the diagnosis, active joint count
and also laboratory parameters as ESR, ANA, RF and
HLA-B27 antigen. While it was not statistically sig-
nificant, all seropositive patients were in the TMJ
arthritis positive group. Differences in CRP was statis-
tically significant - higher CRP was in the TMJ arth-
ritis group (p = 0.03).
Our results revealed that there are general JIA risk al-
leles in JIA patients’ groups versus controls such as
DRB1*07:01 that was found in the total JIA group and
MRI positive group. Risk alleles for JIA as DQB1*03:03;
DQB1*05:01 were detected in total JIA group and MRI
negative group. Also some protective alleles as
DRB1*18:01(in total JIA group and MRI positive group),
DQB1*06:02-8 (in total JIA group and MRI negative
group) were found.
Regarding TMJ arthritis alleles, DRB1*12:01, DQB1*03:01
and DQA1*05:01 appeared to be protective when
comparing MRI positive versus MRI negative groups.
We did not find any convincing risk alleles for TMJ
arthritis (See Table 2).
Discussion
In the study of United Kingdom children [15],
DRB1*07:01 was associated with a decreased risk for
persistent oligoarthritis, RF positive and negative polyar-
thritis and enthesitis related arthritis. Similar findings
are described in Mexicans [16]. Surprisingly, our results
show DRB1*07:01 as a risk allele in the total JIA patient
group compared to control group and also in those with
TMJ arthritis (patients with polyarticular disease course
and different JIA subtypes) (OR = 7,28. p < 0,000). In the
study of Hollenbach et al. [10], they have analysed 802
JIA patients with two most common JIA subtypes -
oligoarthritis (both persistent and extended) and RF
negative polyarthritis. They found several risk haplotypes
regardless of clinical subtype and age of onset, including
DRB1-DQA1-DQB1 haplotypes: DRB1*08:01-DQA1*04:01-
DQB1*04:02 and DRB1*11:03/4-DQA1*05:01-DQB1*03:01.
They also determined that protective haplotypes
DRB1*15:01-DQA1*01:02-DQB1*06:02 were protective.
In our study we also found DQB1*06:02-8 as a protect-
ive allele regardless of TMJ involvement. Similar results
are shown in a study of JIA patients in Colombian Mesti-
zos, where allele DQB1*06:02 was found as protective
[17]. In our study allele DQB1*03:01 appears to have pro-
tective role for TMJ involvement, but in Hollenbach’s
study it was protective for early onset oligoarticular-
persistent subtype. There are data in Hollenbach’s study
Table 2 Comparison of HLA alleles between TMJ arthritis positive and TMJ negative patient groups and control groups
Alleles of risk OR (p) Protective alleles OR (p)
DRB1
Total JIA group (n = 85) versus control (n = 100) DRB1*07:01 7.28(0.000) DRB*18:01 0.10(0.000)
TMJ arthritis positive group (n = 62) versus control (n = 100) DRB1*13:01 1.88(0.031) DRB1*18:01 0.13(0.001)
DRB1*07:01 8.87(0.000)
TMJ arthritis negative group (n = 23) versus control (n = 100) DRB1*11:01 2.97(0.002) - -
TMJ positive (n = 62) versus TMJ negative (n = 23) group - - DRB*12:01 0.35(0.005)
DQB1
Total JIA group (n = 85) versus control (n = 100) DQB1*03:03 2.03(0.052) DQB1*06:01 0.20(0.024)
DQB1*05:01 2.10(0.011) DQB1*0602–8 0.56(0.028)
TMJ arthritis positive group (n = 62) versus control (n = 100) - - - -
TMJ arthritis negative group (n = 23) versus control (n = 100) DQB1*0301 2.42(0.011) DQB1*0602–8 0.293(0.018)
DQB1*03:03 2.582(0.051)
DQB1*05:01 3.187(0.002)
TMJ positive (n = 62) versus TMJ negative (n = 23) group - - DQB1*03:01 0.41(0.017)
DQA1
Total JIA group (n = 85) versus control (n = 100) - - - -
TMJ arthritis positive group (n = 62) versus control (n = 100) - - - -
TMJ arthritis negative group (n = 23) versus control (n = 100) - - DQA1*02:01 0.163(0.046)
TMJ positive (n = 62) versus TMJ negative (n = 23) group - - DQA1*05:01 0.33(0.009)
OR odds ratio, p < 0,05
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suggesting that the presence of two predisposing DRB1
alleles is associated with a significantly greater predispos-
ition to disease than a single one. We are also planning to
analyse similar data in our study. As in our results,
DRB1*03 was found less frequent in JIA patients than in
control group in Hungarian patients [18].
A protective role of the alleles DRB1*12:01, DQB1*03:01;
DQA1*05:01 in the development of TMJ arthritis may be
associated with a less aggressive disease course (e.g.,these
patients had a lower CRP) and consequently less radio-
logical damage. This trend has to be analysed in the future
by evaluating patients who have these alleles more carefully
and over long-term course regardless of TMJ involvement.
When analysing HLA II class alleles, we must take
into account the differences of nationality and different
genetic background since most of our patients are of
Latvian or Russian descent. Also there should be more
evaluation and discussion of the associations between
ILAR groups and TMJ involvement; in this study we di-
vided the groups into MRI-confirmed and MRI-non
confirmed TMJ arthritis and could not take into ac-
count, how disease could change over time with TMJ de-
veloping in the future. Most of our patients were already
adolescents with mean disease duration of 3 years and it
might be that the disease course was already established.
We suspect that TMJ arthritis can be used as a prog-
nostic feature for disease course. Identifying risk and
protective HLA II class haplotypes could help to predict
TMJ arthritis development in the future that in turn
could help to treat and prevent TMJ joint damage in
high risk patients. We will evaluate further other charac-
teristics of the patients with TMJ involvement that could
help to detect JIA patients who need early and regular
evaluation with MRI. It would be important to analyse
HLA II class alleles in more homogeneous groups of JIA to
see if the same results about protective alleles are found.
Conclusions
In our study there were no convincing risk alleles, but
there are alleles with probable protective role for TMJ
arthritis such as DRB1*12:01, DQB1*03:01; DQA1*05:01.
Further analysis of different haplotypes may help us
detect HLA II class alleles that can be used in the early
detection of high risk for TMJ arthritis.
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